Cognition Therapeutics (CGTX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov13

Cognition Therapeutics Inc. Completes Enrollment for Phase 2 Clinical Trial of Early Alzheimer's Disease

12:37

Nov7

Cognition Therapeutics released FY2025 9 Months Earnings on November 6, 2025 (EST), with actual revenue of USD 0 and actual EPS of USD -0.3132

04:00

Cognition Therapeutics released FY2025 Q3 earnings on November 6, 2025 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0632 (forecast USD -0.09)

04:00

Aug8

Cognition Therapeutics released FY2025 Semi-Annual Earnings on August 7, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.2447

03:00

Cognition Therapeutics released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.11 (forecast USD -0.105)

03:00

Aug7

Cognition Therapeutics Q2 Net Loss of $6.7M, Significant Progress in Alzheimer's Drug Development

20:00